Drug intelligence / Profile preview

alstonine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral (traditional Use), Intraperitoneal (preclinical Studies)
01

Overview

**Alstonine** is a plant-derived indole alkaloid, naturally occurring in various species such as *Alstonia boonei*, *Rauvolfia vomitoria*, and *Catharanthus roseus*.[1][5] It is a pentacyclic compound with putative antipsychotic activity, traditionally used in Nigerian herbal medicine for mental illnesses[3][7]. Preclinical studies indicate a potent antipsychotic profile, reducing hyperlocomotion, stereotypy, and social withdrawal in animal models, with additional anxiolytic-like, anticancer, and antimalarial effects[1][3][5][6][7][8]. Mechanistically, alstonine appears to modulate serotonergic (5-HT2A, 5-HT2C) and dopaminergic pathways, increasing serotonergic signaling and intraneuronal dopamine catabolism, with indications of serotonin receptor agonism and indirect glutamate uptake inhibition[7][5]. Alstonine lacks extrapyramidal or metabolic side effects typical of established antipsychotics in animal studies[7][3].

Other names
alstonin3,4,5,6,16,17-Hexadehydro-16-(methoxycarbonyl)-19alpha-methyl-20alpha-oxayohimbaniumNCI60_041680C09028C-09028C 0902820alpha-Oxayohimbanium, 3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19alpha-methyl-UNII-SB0M27Q90XUNII-SB-0M27Q90XUNII-SB 0M27Q90XCHEBI:2612methyl (15S,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1,3,5,7,9,11,18-heptaene-19-carboxylate
02

Targets

HTR2A (Serotonin receptor 5-HT2A)HTR2C (5-hydroxytryptamine 2C receptor)DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on alstonine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alstonine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call